EUVIMEDEUVIMED entdecken
Crossref

Chronic cortisol elevation impairs insulin sensitivity and glucagon-mediated fasting glycaemia

Sofia João Nogueira, Ana Filipe Lima, Tiago Teixeira, Vitor Francisco, Joana Brito

Science Letters · 17.04.2026

DOI: 10.48797/sl.2026.490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Letters, erschienen am 17.04.2026. Verfasst von Sofia João Nogueira und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic cortisol elevation, from prolonged stress, Cushing's syndrome, or therapeutic glucocorticoids, disrupts glucose homeostasis by impairing insulin signalling and enhancing hepatic glucose production, yet integrated hormonal mechanisms remain incompletely characterized [1,2].

Objective

This work aims to systematically review how chronic hypercortisolism affects: (I) peripheral insulin sensitivity; (II) compensatory glucagon secretion and hepatic sensitivity; and (III) fasting glycaemia maintenance in adult populations [2,3].

Methods

Systematic search (MEDLINE, Scopus, 2014–2025) of human studies reporting chronic cortisol/glucocorticoid exposure (endogenous or iatrogenic) and fasting metabolic outcomes. Inclusion criteria: adults (≥18 years) with measurements of fasting glycaemia, hepatic glucose production, insulin sensitivity, glucagon levels, or counterregulatory responses. Exclusion criteria: paediatric studies, pregnancy/lactation, animal/in vitro models, or studies lacking fasting measures or cortisol/glucagon data [4]. Thirteen peer-reviewed articles were synthesized.

Results

Chronic excess of cortisol consistently impairs peripheral insulin sensitivity through post-receptor signalling defects and enhanced lipolysis, reducing insulin-dependent glucose uptake by skeletal muscle and adipose tissue [1,4]. Simultaneously, cortisol attenuates insulin's suppression of glucagon and increases hepatic glucagon receptor sensitivity, amplifying hepatic glucose production and gluconeogenesis [3]. These dual defects, diminished insulin efficacy combined with exaggerated glucagon actions, sustain fasting hyperglycaemia [2]. Central neural dysregulation and disrupted circadian feedback loops further destabilize basal glucose control, particularly in populations with obesity or prediabetes [3,5].

Conclusions

Chronic hypercortisolism triggers coordinated insulin–glucagon axis imbalance, impairing fasting glycaemia maintenance through combined peripheral resistance and enhanced hepatic glucose output [1]. Targeting hypothalamic–pituitary–adrenal (HPA) axis modulation and stress reduction may prevent glucocorticoid-related dysglycemia [2]. Standardized prospective cohort studies with detailed biomarker kinetics and longitudinal follow-up are essential to establish glucocorticoid-induced prediabetes risk profiles and evidence-based intervention strategies [4,5].

Schlagwörter

glucocorticoidsinsulin sensitivityinsulin resistanceglucagon secretionhepatic glucose productiongluconeogenesiscounterregulatory responsehypothalamic-pituitary-adrenal axisprediabetesobesity

Zitieren

APA

Nogueira, S. J., Lima, A. F., Teixeira, T., Francisco, V., & Brito, J. (2026). Chronic cortisol elevation impairs insulin sensitivity and glucagon-mediated fasting glycaemia. Science Letters. https://doi.org/10.48797/sl.2026.490

Vancouver

Nogueira SJ, Lima AF, Teixeira T, Francisco V, Brito J. Chronic cortisol elevation impairs insulin sensitivity and glucagon-mediated fasting glycaemia. Science Letters. 2026. doi:10.48797/sl.2026.490

BibTeX
@article{Nogueira2026,
  author = {Nogueira, Sofia João and Lima, Ana Filipe and Teixeira, Tiago and Francisco, Vitor and Brito, Joana},
  title = {Chronic cortisol elevation impairs insulin sensitivity and glucagon-mediated fasting glycaemia},
  journal = {Science Letters},
  year = {2026},
  doi = {10.48797/sl.2026.490}
}
Kostenlos starten →